Wada, N., Murakami, T., Fauzi, M., Sakaki, K., Oshima, S., Shimada, Y., Asai, K., Oshima, A., Nomura, S., Joo, E., Mori, M., Fujiwara, R., Shide, K., Wada, K., Yabe, D., Inagaki, N., & Harada, N. (2024). Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. Journal of Clinical Medicine Research, 16(10), 503-508. https://doi.org/10.14740/jocmr6031